Literature DB >> 31746273

Endovascular Approach Versus Aortobifemoral Bypass Grafting: Outcomes in Extensive Aortoiliac Occlusive Disease.

João Rocha-Neves1,2,3, André Ferreira2, Joel Sousa1,3, António Pereira-Neves1,2, José Vidoedo4, Hélio Alves2, José Teixeira1, Ana Azevedo5,6,7.   

Abstract

OBJECTIVE: Compare technical, clinical, and economic outcomes between endovascular and open approaches in patients with type D aortoiliac occlusive disease according to the TransAtlantic Inter-Society Consensus.
METHODS: Patients undergoing revascularization for type D aortoiliac lesions, either endovascular or open surgery approach, from 2 Portuguese institutions between January 2011 and October 2017 were included. The surgical technique was left to the surgeon discretion. Patients with common femoral artery affection, both obstructive and aneurysmatic, were excluded.
RESULTS: Twenty-seven patients underwent aortobifemoral bypass and 32 patients were submitted to endovascular repair. The patients undergoing endovascular procedure were more likely to present with chronic heart failure (P = .001) and chronic kidney disease (P = .022) and less likely to have a history of smoking (P = .05). The mean follow-up period was 67.84 (95% confidence interval = 61.85-73.83) months. The open surgery approach resulted in a higher technical success (P = .001); however, limb salvage and patency rates were not different between groups. Endovascular approach was associated with a shorter length-of-stay, both inpatient (6 vs 9 days; P = .041) and patients admitted in the intensive care unit (0 vs 3.81 days; P = .001) as well as lower hospital expenses (US$9281 vs US$23 038; P = .001) with a similar procedure cost (US$2316 vs US$1173; P = .6). No differences were found in the postsurgical quality of life.
CONCLUSION: Endovascular approach is, at least, clinically equivalent to open surgery approach and is more cost-efficient. The "endovascular-first" approach should be considered for type D occlusive aortoiliac lesions.

Entities:  

Keywords:  arterial occlusive diseases; blood vessel prosthesis implantation; endovascular procedure; vascular grafting

Mesh:

Year:  2019        PMID: 31746273     DOI: 10.1177/1538574419888815

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  3 in total

1.  Hybrid Repair Combined with Fresh Arterial Allograft Extra-Anatomical Reconstruction: The Treatment of Infrarenal Abdominal Aneurysm above an Aortobifemoral Bypass Complicated by an Infected Pseudoaneurysm in the Left Groin.

Authors:  Robert Novotny; Tomas Marada; Jiri Novotny; Jakub Kristek; Jaroslav Chlupac; Michal Kudla; Kvetoslav Lipar; Jiri Mendl; Jiri Fronek; Libor Janousek
Journal:  Case Rep Vasc Med       Date:  2020-11-07

2.  Leriche Syndrome with Digital Gangrene: Is Aortic Bypass Grafting Safe in Intravenous Drug Abusers? A Case Report and Literature Review.

Authors:  Syed Muhammad Hammad Ali; Ossama Ather; Aasim Malik
Journal:  Vasc Specialist Int       Date:  2022-03-31

3.  Myocardial injury after aortoiliac revascularization for extensive disease: A survival analysis.

Authors:  Juliana Pereira-Macedo; Neuza Machado; António Pereira-Neves; Vítor Ferreira; José Oliveira-Pinto; Marina Dias-Neto; João Rocha-Neves; José Teixeira; José Andrade
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-07-28       Impact factor: 0.332

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.